Quest Diagnostics Inc DGX インサイダー取引

Quest Diagnostics Inc (DGX) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-06-01	Mr. James E. DavisChairman, CEO & President	-10.00k	1.94M	Automatic Disposition	194.14	132.42k	-7.02%
2026-03-05	Mr. Michael E. PrevoznikSenior VP & General Counsel	-3.88k	799.68k	Automatic Disposition	206.21	43.29k	-8.22%
2026-03-04	Mr. Michael E. PrevoznikSenior VP & General Counsel	-3.35k	687.10k	Sale to Issuer	204.86	43.29k	-7.19%
2026-03-04	Mr. Mark E. DelaneySenior VP & Chief Commercial Officer	-2.33k	476.50k	Sale to Issuer	204.86	11.86k	-16.39%
2026-03-05	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-5.56k	1.15M	Automatic Disposition	206.21	71.62k	-7.20%
2026-03-04	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-5.81k	1.19M	Sale to Issuer	204.86	71.62k	-7.50%
2026-03-04	Mr. Sam A. SamadExec. VP & CFO	-7.72k	1.58M	Sale to Issuer	204.86	33.27k	-18.83%
2026-03-05	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-2.86k	588.73k	Automatic Disposition	206.21	15.20k	-15.81%
2026-03-04	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-2.83k	579.14k	Sale to Issuer	204.86	15.20k	-15.68%
2026-03-04	Mr. James E. DavisChairman, CEO & President	-26.41k	5.41M	Sale to Issuer	204.86	142.42k	-15.64%
2026-03-04	Mr. Michael J. DeppeSenior VP, Corporate Controller & CAO	-750.00	153.65k	Sale to Issuer	204.86	35.90k	-2.05%
2026-03-04	Mr. Karthik KuppusamySVP of Clinical Solutions	-2.63k	538.37k	売り	204.86	15.46k	-14.53%
2026-03-03	Mr. Michael E. PrevoznikSenior VP & General Counsel	-526.00	109.27k	Automatic Disposition	207.73	43.29k	-1.20%
2026-03-02	Mr. Michael E. PrevoznikSenior VP & General Counsel	-288.00	59.00k	Sale to Issuer	204.86	43.29k	-0.66%
2026-03-03	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-632.00	131.29k	Automatic Disposition	207.73	71.62k	-0.87%
2026-03-02	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-648.00	132.75k	Sale to Issuer	204.86	71.62k	-0.90%
2026-03-02	Mr. Sam A. SamadExec. VP & CFO	-869.00	178.02k	Sale to Issuer	204.86	27.04k	-3.11%
2026-03-03	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-410.00	85.17k	Automatic Disposition	207.73	15.20k	-2.63%
2026-03-02	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-230.00	47.12k	Sale to Issuer	204.86	15.20k	-1.49%
2026-03-02	Mr. James E. DavisChairman, CEO & President	-10.00k	2.13M	Automatic Disposition	212.52	117.19k	-7.86%
2026-03-02	Mr. James E. DavisChairman, CEO & President	-2.97k	608.02k	Sale to Issuer	204.86	117.19k	-2.47%
2026-03-02	Mr. Mark E. DelaneySenior VP & Chief Commercial Officer	-188.00	38.51k	Sale to Issuer	204.86	8.51k	-2.16%
2026-03-02	Mr. Karthik KuppusamySVP of Clinical Solutions	-205.00	42.00k	Sale to Issuer	204.86	11.89k	-1.70%
2026-03-02	Mr. Michael J. DeppeSenior VP, Corporate Controller & CAO	-88.00	18.03k	Sale to Issuer	204.86	35.18k	-0.25%
2026-02-18	Mr. Sam A. SamadExec. VP & CFO	-1.87k	388.62k	Sale to Issuer	206.99 - 210.01	27.84k	-6.28%
2026-02-19	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-958.00	196.23k	Automatic Disposition	204.83	15.84k	-5.70%
2026-02-18	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-537.00	111.89k	Sale to Issuer	206.99 - 210.01	15.84k	-3.28%
2026-02-18	Mr. James E. DavisChairman, CEO & President	-6.18k	1.29M	Sale to Issuer	206.99 - 210.01	130.15k	-4.54%
2026-02-19	Mr. Michael E. PrevoznikSenior VP & General Counsel	-1.11k	227.57k	Automatic Disposition	204.83	44.11k	-2.46%
2026-02-18	Mr. Michael E. PrevoznikSenior VP & General Counsel	-648.00	135.04k	Sale to Issuer	206.99 - 210.01	44.11k	-1.45%
2026-02-18	Mr. Karthik KuppusamySVP of Clinical Solutions	-511.00	106.53k	Sale to Issuer	206.99 - 210.01	12.06k	-4.06%
2026-02-19	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-1.43k	293.52k	Automatic Disposition	204.83	72.91k	-1.93%
2026-02-18	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-1.16k	241.62k	Sale to Issuer	206.99 - 210.01	72.91k	-1.57%
2026-02-18	Mr. Mark E. DelaneySenior VP & Chief Commercial Officer	-435.00	90.66k	Sale to Issuer	206.99 - 210.01	8.68k	-4.77%
2026-02-18	Mr. Michael J. DeppeSenior VP, Corporate Controller & CAO	-182.00	37.92k	Sale to Issuer	206.99 - 210.01	35.27k	-0.51%
2026-02-13	Ms. Catherine T. DohertyExec. VP of Regional Businesses	-26.17k	2.46M	Derivative Exercise and Sale	112.17 - 209.10	72.57k	-
2026-02-10	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-5.66k	465.39k	Derivative Exercise and Sale	121.81 - 204.00	15.38k	-
2025-11-25	Mr. James E. DavisChairman, CEO & President	-55.09k	5.31M	Derivative Exercise and Sale	95.80 - 192.97	120.48k	-
2025-11-25	Ms. Vicky Brown GreggIndependent Director	-1.25k	239.70k	売り	191.76	17.04k	-6.84%
2025-11-18	Mr. Mark E. DelaneySenior VP & Chief Commercial Officer	-7.95k	340.84k	Derivative Exercise and Sale	143.33 - 187.35	7.53k	-
2025-11-05	Mr. James E. DavisChairman, CEO & President	-7.14k	1.25M	Sale to Issuer	175.57	120.48k	-5.60%
2025-10-22	Mr. Gary M. PfeifferIndependent Director	-1.48k	270.32k	売り	182.40	29.43k	-4.79%
2025-10-23	Mr. Gary M. PfeifferIndependent Director	-4.41k	0.00	Derivative Disposition Under Employee Benefit Plan	-	0.00	-100.00%
2025-09-26	Mr. Michael E. PrevoznikSenior VP & General Counsel	-227.00	19.20k	Derivative Exercise and Sale	103.57 - 188.66	43.81k	-
2025-09-23	Mr. Michael E. PrevoznikSenior VP & General Counsel	-28.46k	2.38M	Derivative Exercise and Sale	103.57 - 187.12	43.81k	-
2025-08-21	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-1.98k	365.38k	Automatic Disposition	185.00	15.27k	-11.45%
2025-08-19	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-4.53k	321.00k	Derivative Exercise and Sale	112.17 - 183.00	17.24k	-
2025-08-15	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-1.98k	355.50k	Automatic Disposition	180.00	17.24k	-10.28%
2025-08-13	Mr. Karthik KuppusamySVP of Clinical Solutions	-123.00	21.64k	Sale to Issuer	175.91	10.32k	-1.18%
2025-08-06	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-3.56k	314.60k	Derivative Exercise and Sale	86.63 - 175.00	19.22k	-
2025-08-06	Mr. Patrick T. PlewmanSVP of Diagnostic Services	-1.98k	345.63k	Automatic Disposition	175.00	19.22k	-9.32%
2025-07-30	Mr. Karthik KuppusamySVP of Clinical Solutions	-8.27k	534.47k	Derivative Exercise and Sale	86.63 - 167.40	10.44k	-
2025-07-31	Mr. Karthik KuppusamySVP of Clinical Solutions	-2.21k	375.70k	Automatic Disposition	170.00	10.44k	-17.47%
2025-07-16	Mr. Sam A. SamadExec. VP & CFO	-850.00	143.66k	Sale to Issuer	169.01	25.60k	-3.21%